Noval Menéndez J, Nuño Mateo F, Anitúa Roldán M J, López Muñiz A, Fuente Martín E, Gallo Alvaro C
Servicio de Medicina Interna, Hospital de Cabueñes, Gijón.
An Med Interna. 1998 Oct;15(10):534-7.
Rendu-Osler-Weber's disease or Hereditary Hemorrhagic Telangiectasia (HTT) is an autosomal dominant hereditary clinical entity characterized by the presence of telangiectasias on skin, mucous membranes and internal organs. The incidence of hepatic, pulmonary or cerebral complications justifies an early diagnostic. A familiar study of patients previously diagnosed of HTT in our hospital was made, establishing a protocol for the identification of asymptomatic or pauci-symptomatic cases. Fourteen patients were studied: 6 with a previous diagnostic, and 8 familiar contacts. Penetrance was of 85%. Epistaxis (80%) and telangiectasias on skin were the most frequent clinical findings. The visceral lesions found were gastrointestinal (28%), hepatic (15%), urological (15%) and pulmonary (7%). All patients were included in an hepatitis B virus vaccination program. It was also made a morphological study with Werhoeff's staining of the elastic layer, that allowed to distinguish both arterial and venous alterations.
遗传性出血性毛细血管扩张症(Rendu-Osler-Weber病或HTT)是一种常染色体显性遗传性临床病症,其特征为皮肤、黏膜和内脏器官出现毛细血管扩张。肝、肺或脑并发症的发生率使得早期诊断很有必要。我们对我院先前诊断为HTT的患者进行了家族研究,制定了识别无症状或症状轻微病例的方案。研究了14名患者:6名先前已确诊,8名家族接触者。外显率为85%。鼻出血(80%)和皮肤毛细血管扩张是最常见的临床表现。发现的内脏病变有胃肠道(28%)、肝脏(15%)、泌尿系统(15%)和肺部(7%)。所有患者均纳入乙肝病毒疫苗接种计划。还采用韦霍夫弹性层染色进行了形态学研究,以区分动脉和静脉病变。